These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22683541)

  • 1. Biomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8.
    Na HJ; Hamilton RG; Klion AD; Bochner BS
    J Immunol Methods; 2012 Sep; 383(1-2):39-46. PubMed ID: 22683541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siglec-7 on peripheral blood eosinophils: Surface expression and function.
    Legrand F; Landolina N; Zaffran I; Emeh RO; Chen E; Klion AD; Levi-Schaffer F
    Allergy; 2019 Jul; 74(7):1257-1265. PubMed ID: 30690753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Siglec-8 is regulated by interleukin-5, and serum levels of soluble Siglec-8 may predict responsiveness of severe eosinophilic asthma to mepolizumab.
    Arakawa S; Suzukawa M; Ohshima N; Tashimo H; Asari I; Matsui H; Kobayashi N; Shoji S; Nagase T; Ohta K
    Allergol Int; 2018 Sep; 67S():S41-S44. PubMed ID: 29703694
    [No Abstract]   [Full Text] [Related]  

  • 5. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x.
    Hudson SA; Bovin NV; Schnaar RL; Crocker PR; Bochner BS
    J Pharmacol Exp Ther; 2009 Aug; 330(2):608-12. PubMed ID: 19458105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of activated eosinophils in infants with severe atopic dermatitis.
    Toma T; Mizuno K; Okamoto H; Kanegane C; Ohta K; Ikawa Y; Miura M; Kuroda M; Niida Y; Koizumi S; Yachie A
    Pediatr Int; 2005 Feb; 47(1):32-8. PubMed ID: 15693863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
    O'Sullivan JA; Wei Y; Carroll DJ; Moreno-Vinasco L; Cao Y; Zhang F; Lee JJ; Zhu Z; Bochner BS
    J Leukoc Biol; 2018 Jul; 104(1):11-19. PubMed ID: 29601103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge.
    Johansson MW; Kelly EA; Nguyen CL; Jarjour NN; Bochner BS
    Int Arch Allergy Immunol; 2018; 177(1):16-28. PubMed ID: 29879704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily.
    Floyd H; Ni J; Cornish AL; Zeng Z; Liu D; Carter KC; Steel J; Crocker PR
    J Biol Chem; 2000 Jan; 275(2):861-6. PubMed ID: 10625619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of major basic protein in patients with or without eosinophilia: measurement by enzyme-linked immunosorbent assay.
    Yamamoto H; Ninomiya H; Yoshimatsu K; Uchiyama Y; Shibasaki M; Enokihara H; Tachibana S; Abe T
    Br J Haematol; 1994 Mar; 86(3):490-5. PubMed ID: 8043431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery, Function, and Therapeutic Targeting of Siglec-8.
    Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum eosinophilia and total immunoglobulin E concentration with the risk of allergic symptoms and allergic sensitization, respectively: A 2-year follow-up study.
    Park SC; Kim JH; Lee KH; Hong SC; Lee HS; Kang JW
    Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():167-71. PubMed ID: 27260601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bochner BS; Rasmussen HS; Peterson K; Bebbington C; Tomasevic N
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
    Farid SSh; Mirshafiey A; Razavi A
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olig2 is expressed late in human eosinophil development and controls Siglec-8 expression.
    Hwang SM; Uhm TG; Lee SK; Kong SK; Jung KH; Binas B; Chai YG; Park SW; Chung IY
    J Leukoc Biol; 2016 Oct; 100(4):711-723. PubMed ID: 27154355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.
    O'Sullivan JA; Carroll DJ; Cao Y; Salicru AN; Bochner BS
    J Allergy Clin Immunol; 2018 May; 141(5):1774-1785.e7. PubMed ID: 28734845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin preparations contain anti-Siglec-8 autoantibodies.
    von Gunten S; Vogel M; Schaub A; Stadler BM; Miescher S; Crocker PR; Simon HU
    J Allergy Clin Immunol; 2007 Apr; 119(4):1005-11. PubMed ID: 17337295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalized serum eosinophil peroxidase levels are inversely correlated with esophageal eosinophilia in eosinophilic esophagitis.
    Wright BL; Ochkur SI; Olson NS; Shim KP; Jacobsen EA; Rank MA; Dellon ES; Lee JJ
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29228243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation.
    Tomassini M; Tsicopoulos A; Tai PC; Gruart V; Tonnel AB; Prin L; Capron A; Capron M
    J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):365-75. PubMed ID: 1890265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Siglec"ting the allergic response for therapeutic targeting.
    Bochner BS
    Glycobiology; 2016 Jun; 26(6):546-52. PubMed ID: 26911285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.